Exact Mass: 413.1158

Exact Mass Matches: 413.1158

Found 55 metabolites which its exact mass value is equals to given mass value 413.1158, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glucose lactate glutamate

2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl 4-amino-5-[(2-hydroxypropanoyl)peroxy]-5-oxopentanoic acid

C14H23NO13 (413.1169)


   
   

Methyl anhydroberberillate

Methyl anhydroberberillate

C21H19NO8 (413.1111)


   

L-|A-Glutamyl-S-[(4-hydroxyphenyl)methyl]-L-cysteinylglycine

L-|A-Glutamyl-S-[(4-hydroxyphenyl)methyl]-L-cysteinylglycine

C17H23N3O7S (413.1257)


   

Bicucullinine

Bicucullinine

C21H19NO8 (413.1111)


   

Aureonuclemycin

Aureonuclemycin

C15H19N5O9 (413.1183)


   
   
   

S-(4-Hydroxybenzyl)glutathione

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(4-hydroxyphenyl)methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C17H23N3O7S (413.1257)


S-(4-Hydroxybenzyl)glutathione is a natural product found in Gastrodia elata with data available. S-(4-Hydroxybenzyl)glutathione is a glutathione derivative. S-(4-Hydroxybenzyl)glutathione inhibits the in vitro binding of kainic acid to brain glutamate receptors, with an IC50 of 2 μM[1].

   
   
   
   
   
   
   

Ser-Trp-OH

(S)-2-(3-(2-hydroxyethoxy)-4-nitrobenzamido)-3-(1H-indol-3-yl)propanoic acid

C20H19N3O7 (413.1223)


   

Trp-Ser-OH

(S)-2-(3-(2-(1H-indol-3-yl)ethoxy)-4-nitrobenzamido)-4-hydroxybutanoic acid

C20H19N3O7 (413.1223)


   

R306465

N-hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide

C19H19N5O4S (413.1158)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   
   
   

NU7441(KU-57788)

8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one

C25H19NO3S (413.1086)


   

[7-(4-nitrooxybutoxy)-4-oxo-2-phenylchromen-5-yl] acetate

[7-(4-nitrooxybutoxy)-4-oxo-2-phenylchromen-5-yl] acetate

C21H19NO8 (413.1111)


   

Disperse Blue 148

Disperse Blue 148

C19H19N5O4S (413.1158)


   

(4-cyanobenzyl)triphenylphosphonium chloride

(4-cyanobenzyl)triphenylphosphonium chloride

C26H21ClNP (413.11)


   

2-(2,6-dichlorobenzyl)-6-phenyl-5-piperidino-3(2H)-pyridazinone

2-(2,6-dichlorobenzyl)-6-phenyl-5-piperidino-3(2H)-pyridazinone

C22H21Cl2N3O (413.1062)


   

4-({4-[(4-Aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide

4-({4-[(4-Aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide

C17H23N3O5S2 (413.1079)


   

N(6)-(dimethylallyl)adenosine 5-phosphate(2-)

N(6)-(dimethylallyl)adenosine 5-phosphate(2-)

C15H20N5O7P-2 (413.11)


   
   

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 4-amino-5-(2-hydroxypropanoylperoxy)-5-oxopentanoate

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 4-amino-5-(2-hydroxypropanoylperoxy)-5-oxopentanoate

C14H23NO13 (413.1169)


   

6-[[(2-Ethoxy-1-naphthalenyl)carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

6-[[(2-Ethoxy-1-naphthalenyl)carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C21H21N2O5S- (413.1171)


   

(+)-Malbrancheamide C

(+)-Malbrancheamide C

C21H24BrN3O (413.1103)


   

N-(4-acetylphenyl)-2-[[1-(3,5-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide

N-(4-acetylphenyl)-2-[[1-(3,5-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide

C19H19N5O4S (413.1158)


   

(+)-Isomalbrancheamide C

(+)-Isomalbrancheamide C

C21H24BrN3O (413.1103)


   

2-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]sulfanyl-3-ethyl-5,6-dimethylthieno[2,3-d]pyrimidin-4-one

2-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]sulfanyl-3-ethyl-5,6-dimethylthieno[2,3-d]pyrimidin-4-one

C21H23N3O2S2 (413.1232)


   
   
   
   
   
   
   
   

diaquabis(L-histidine)copper(2+)

diaquabis(L-histidine)copper(2+)

C12H26CuN6O6+4 (413.121)


   
   
   

LUF6096

LUF6096

C22H21Cl2N3O (413.1062)


LUF6096, a potent allosteric enhancer of the adenosine A3 receptor, is able to allosterically enhance agonist binding. LUF6096 shows low orthosteric affinity for any of the adenosine receptors. LUF6096 shows protective effects in myocardial ischemia/reperfusion injury[1][2].

   

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C17H23N3O7S (413.1257)


   

2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

C21H19NO8 (413.1111)


   

4,5,7-trihydroxy-n-(1-methoxy-3-methyl-1-oxobutan-2-yl)-9,10-dioxoanthracene-2-carboximidic acid

4,5,7-trihydroxy-n-(1-methoxy-3-methyl-1-oxobutan-2-yl)-9,10-dioxoanthracene-2-carboximidic acid

C21H19NO8 (413.1111)


   

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C17H23N3O7S (413.1257)


   

4,5,7-trihydroxy-n-[(2s)-1-methoxy-3-methyl-1-oxobutan-2-yl]-9,10-dioxoanthracene-2-carboximidic acid

4,5,7-trihydroxy-n-[(2s)-1-methoxy-3-methyl-1-oxobutan-2-yl]-9,10-dioxoanthracene-2-carboximidic acid

C21H19NO8 (413.1111)


   

(2s,3s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

(2s,3s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

C21H19NO8 (413.1111)


   

5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid

5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid

C21H19NO8 (413.1111)


   

(1s,13s,15s)-7-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-7-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H24BrN3O (413.1103)


   

methyl 3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoate

methyl 3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoate

C21H19NO8 (413.1111)


   

(1s,13s,15s)-6-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-6-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H24BrN3O (413.1103)